The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Javier A. Menendez
Fundació d'Investigació Biomédica de Girona Dr. Josep Trueta (IdIBGi)
Girona
Spain
Name/email consistency: high
- HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail". Menéndez, J.A., Vázquez-Martín, A., Ropero, S., Colomer, R., Lupu, R. Clinical. &. Translational. Oncology. :. Official. Publication. Federation. Spanish. Oncology. Societies. National. Cancer. Institute. Mexico (2006)
- Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Menendez, J.A., Lupu, R. Curr. Pharm. Biotechnol (2006)
- In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells. Menendez, J.A., Decker, J.P., Lupu, R. J. Cell. Biochem. (2005)
- Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis. Menendez, J.A., Colomer, R., Lupu, R. Med. Hypotheses (2005)
- Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?. Menendez, J.A., Colomer, R., Lupu, R. Med. Hypotheses (2005)
- Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells. Menendez, J.A., Vellon, L., Lupu, R. Med. Hypotheses (2005)
